Piramal Pharma Raises Annual Growth Guidance
Chairperson Nandini Piramal said the company raised its annual growth guidance from the low-to-mid teens to the upper end of its stated range, expecting a significantly stronger second half.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.